![]() |
市場調査レポート
商品コード
1494888
特殊酵素市場の2030年までの予測:タイプ別、由来別、用途別、エンドユーザー別、地域別の世界分析Specialty Enzymes Market Forecasts to 2030 - Global Analysis By Type (Carbohydrases, Proteases, Lipases, Polymerases & Nucleases and Other Types), Source, Application, End User and By Geography |
||||||
カスタマイズ可能
|
特殊酵素市場の2030年までの予測:タイプ別、由来別、用途別、エンドユーザー別、地域別の世界分析 |
出版日: 2024年06月06日
発行: Stratistics Market Research Consulting
ページ情報: 英文 200+ Pages
納期: 2~3営業日
|
Stratistics MRCによると、世界の特殊酵素市場は2024年に15億米ドルを占め、予測期間中のCAGRは8.7%で成長し、2030年には25億米ドルに達すると予測されています。
特殊酵素は、医薬品、診断、食品加工、バイオテクノロジーなどの様々な産業における特定の用途に合わせて調整されることが多い、ユニークな特性と機能を示す酵素のクラスです。これらの酵素は、特定の条件下で特定の反応を効率的に触媒する能力によって特徴付けられ、様々な産業プロセスにとって貴重なツールとなります。特殊酵素は、人工酵素、精製酵素、天然酵素のいずれであってもよく、通常、高い基質特異性と安定性を有しているため、従来の酵素では効果的に達成できない作業を行うことができます。
医薬品と診断における需要の高まり
酵素は医薬品開発、製造、疾病検出において重要な役割を果たすため、医薬品・診断分野での需要が急増しています。酵素の特異性と効率性により、酵素は医薬品製剤に不可欠であり、薬剤の合成と精製を助ける。さらに、診断学においては、酵素は様々なアッセイキットの重要な構成要素として機能し、正確な疾病診断とモニタリングを容易にしています。このような需要の高まりは、特殊酵素がヘルスケアの解決策を進める上で極めて重要な役割を果たしていることを裏付けるものであり、市場の有望な成長軌道を裏付けています。
従来のプロセスとの競合
市場は従来のプロセスとの厳しい競争に直面しており、大きな課題となっています。伝統的な製法は多くの場合、慣れ親しんで確立されたプロトコルを提供するため、特殊酵素が特定の業界に浸透するのは困難です。さらに、消費者の中には、従来のプロセスの方が信頼性が高く、費用対効果に優れていると認識する人もおり、市場の成長を妨げています。特殊酵素メーカーが成功を収めるには、効率性、特異性、持続可能性の向上といった明確な利点を示して、従来の方法よりも自社製品を採用するよう業界に説得しなければならないです。
製造業における生体触媒作用の台頭
生体触媒作用とは、酵素のような生物学的システムによる触媒作用のことで、市場で急成長を遂げています。この増加は主に、環境に優しい性質、費用対効果、高い特異性によるものです。特に医薬品、飲食品、バイオ燃料などの製造プロセスにおいて、生物触媒を採用する産業が増加しています。酵素は、穏やかな反応条件やエネルギー消費の削減といった利点を提供します。持続可能性とグリーン・ケミストリーが重視されるようになるにつれて、生物触媒は様々なセクターの製造慣行に革命を起こす上で極めて重要な役割を果たすようになってきています。
酵素生産コストの高さ
市場は、酵素生産コストの高さによる大きな課題に直面しています。このハードルは、抽出・精製プロセスや製造に必要な高度な技術に関わる複雑さから生じています。加えて、厳格な品質管理措置が生産コストをさらに押し上げます。このようなコストの上昇は、価格戦略に影響を与え、利益率を低下させる可能性があるため、生産効率を最適化し、費用対効果を高める革新的なソリューションが必要となり、市場の成長を制限する可能性があります。
市場はCOVID-19による変化を目の当たりにしています。当初はサプライチェーンや製造の混乱により生産が鈍化したが、診断キット用酵素の需要が増加し、COVID-19治療法の調査も急増しました。パンデミックの進行に伴い、健康志向へのシフトが医薬品、栄養補助食品、バイオテクノロジーにおける酵素需要を押し上げています。市場は新たな規範に適応し、抗ウイルス酵素の研究に重点を置き、ワクチン開発と診断技術の機会を模索し、弾力的で進化する状況を形成しています。
微生物酵素セグメントは予測期間中最大となる見込み
微生物酵素は予測期間中最大となる見込みです。その用途は、飲食品加工、医薬品、繊維製品、バイオ燃料生産など多岐にわたる。アミラーゼ、プロテアーゼ、リパーゼ、セルラーゼなどの主要な微生物酵素は、特定の反応を正確に触媒する能力があるため、高い人気があります。バイオテクノロジーの進歩と持続可能なソリューションへの需要の高まりにより、微生物酵素は特殊酵素市場を独占し続け、技術革新を推進し、多様な産業ニーズに応えています。
予測期間中、医薬品分野が最も高いCAGRが見込まれる
医薬品分野は予測期間中に最も高いCAGRが見込まれます。これらの酵素は、医薬品の製剤化、合成、精製プロセスなど、医薬品製造の様々な段階で極めて重要な役割を果たしています。医薬品製造の効率、特異性、収率を高めるために不可欠であり、それによって新規医薬品やバイオ医薬品の開発が促進されます。この分野では、高度な機能性を持つ高品質の酵素に対する製薬業界の進化する要求に応えるため、絶え間ない技術革新と研究が行われています。
北米は、飲食品やバイオテクノロジーなど様々な産業における需要の増加に牽引され、予測期間中最大の市場シェアを占めると予測されます。技術の進歩、健康とウェルネスに関する消費者の意識の高まり、特殊酵素の用途拡大などの要因が市場拡大を後押ししています。技術革新と持続可能性に焦点を当て、主要企業は積極的に研究開発に投資して斬新な酵素製品を投入し、市場での存在感を高めています。
予測期間中、アジア太平洋地域が最も高いCAGRを維持すると予測されます。同地域では医療費の増加と慢性疾患の流行に伴い、医薬品製造プロセス、診断キット、治療で使用される特殊酵素の需要が高まっています。酵素工学とバイオテクノロジーの進歩により、性能特性が改善された新規酵素が開発されています。このような進歩は、各業界における特殊酵素の採用を促進し、市場の成長に寄与しています。
Market Outlook, By Type (2022-2030) ($MN)
According to Stratistics MRC, the Global Specialty Enzymes Market is accounted for $1.5 billion in 2024 and is expected to reach $2.5 billion by 2030 growing at a CAGR of 8.7% during the forecast period. Specialty enzymes are a class of enzymes that exhibit unique properties and functions, often tailored for specific applications in various industries such as pharmaceuticals, diagnostics, food processing, and biotechnology. These enzymes are characterized by their ability to catalyze specific reactions efficiently under specific conditions, making them valuable tools for various industrial processes. Specialty enzymes may be engineered, purified, or naturally occurring, and they typically possess high substrate specificity and stability, enabling them to perform tasks that conventional enzymes cannot accomplish effectively.
Growing demand in pharmaceuticals & diagnostics
The market is witnessing burgeoning demand in pharmaceuticals and diagnostics sectors due to their vital roles in drug development, production, and disease detection. Enzymes' specificity and efficiency make them indispensable in pharmaceutical formulations, aiding in drug synthesis and purification. Moreover, in diagnostics, enzymes serve as crucial components in various assay kits, facilitating accurate disease diagnosis and monitoring. This escalating demand underscores the pivotal role specialty enzymes play in advancing healthcare solutions and underscores the market's promising growth trajectory.
Competition from traditional processes
The market faces stiff competition from traditional processes, posing significant challenges. Traditional methods often offer familiarity and established protocols, making it challenging for specialty enzymes to penetrate certain industries. Moreover, some consumers may perceive traditional processes as more reliable or cost-effective, hindering the market's growth. To thrive, specialty enzyme manufacturers must showcase distinct advantages such as enhanced efficiency, specificity, and sustainability to convince industries to adopt their products over conventional methods.
Rise of biocatalysis in manufacturing
Biocatalysis is catalysis through biological systems like enzymes, and it's experiencing a surge in the market. This rise is primarily due to its eco-friendly nature, cost-effectiveness, and high specificity. Industries are increasingly adopting biocatalysis in manufacturing processes, especially in pharmaceuticals, food and beverages, and biofuels. Enzymes offer advantages like mild reaction conditions and reduced energy consumption. With growing emphasis on sustainability and green chemistry, biocatalysis is poised to play a pivotal role in revolutionizing manufacturing practices across various sectors.
High cost of enzyme production
The market faces a significant challenge due to the high cost of enzyme production. This hurdle arises from the complexities involved in the extraction and purification processes, as well as the sophisticated technologies required for manufacturing. Additionally, stringent quality control measures further add to the production expenses. These elevated costs can limit market growth by influencing pricing strategies and potentially reducing profit margins, necessitating innovative solutions to optimize production efficiency and enhance cost-effectiveness.
The market has witnessed shifts due to COVID-19. While initially, disruptions in supply chains and manufacturing slowed down production, increased demand for enzymes in diagnostic kits and research for COVID-19 treatments surged. As the pandemic progresses, a shift towards health consciousness has boosted demand for enzymes in pharmaceuticals, nutraceuticals, and biotechnology. The market is adapting to new norms, emphasizing research in antiviral enzymes and exploring opportunities in vaccine development and diagnostic technologies, shaping a resilient and evolving landscape.
The microbial enzymes segment is expected to be the largest during the forecast period
The microbial enzymes is expected to be the largest during the forecast period. Their wide-ranging applications include food and beverage processing, pharmaceuticals, textiles, and biofuel production. Key microbial enzymes such as amylase, protease, lipase, and cellulase are highly sought after for their ability to catalyze specific reactions with precision. With advancements in biotechnology and increasing demand for sustainable solutions, microbial enzymes continue to dominate the specialty enzymes market, driving innovation and meeting diverse industrial needs.
The pharmaceuticals segment is expected to have the highest CAGR during the forecast period
The pharmaceuticals segment is expected to have the highest CAGR during the forecast period. These enzymes play pivotal roles in various stages of pharmaceutical manufacturing, including drug formulation, synthesis, and purification processes. They are vital for enhancing efficiency, specificity, and yield in pharmaceutical production, thereby facilitating the development of novel drugs and biopharmaceuticals. This sector witnesses continuous innovation and research to meet the evolving demands of the pharmaceutical industry for high-quality enzymes with advanced functionalities.
North America is projected to hold the largest market share during the forecast period driven by increasing demand across various industries such as food and beverages and biotechnology. Factors such as technological advancements, growing consumer awareness regarding health and wellness, and the expanding applications of specialty enzymes are fueling market expansion. With a focus on innovation and sustainability, key players are actively investing in research and development to introduce novel enzyme products, thereby enhancing their market presence.
Asia Pacific is projected to hold the highest CAGR over the forecast period. With the rise in healthcare expenditure and the prevalence of chronic diseases in the region, there's a growing demand for specialty enzymes used in drug manufacturing processes, diagnostic kits, and therapeutic treatments. Advances in enzyme engineering and biotechnology have led to the development of novel enzymes with improved performance characteristics. These advancements are driving the adoption of specialty enzymes across industries, contributing to market growth.
Key players in the market
Some of the key players in Specialty Enzymes market include Novozymes, DuPont , BASF SE, Roche Holding AG, Codexis Inc., Advanced Enzyme Technologies Ltd., Amano Enzyme Inc., AB Enzymes GmbH, Biocatalysts Ltd., Dyadic International Inc., Enzyme Development Corporation, DSM Nutritional Products AG, Aumgene Biosciences, Lonza Group Ltd., BBI Enzymes Ltd., Creative Enzymes and Enzyme Solutions Inc.
In October 2023, BASF strengthened its enzyme technology for detergents and cleaners with the launch of a new enzymes' generation from its Lavergy(R) portfolio. hese offers are part of BASF's Care Chemicals Initiative Care 360° - Solutions for Sustainable Life, the division's cross-business and holistic approach to cover all topics impacting the future of key markets and industries: sustainability, digitalization, innovation, and new approaches to working together.
In February 2023, AB Enzymes and Barentz announced the extension of the distribution agreement for our bake & food enzymes in most of Europe with Barentz. Besides the VERON(R) baking enzymes for bread improver and premix manufacturers, flour mills, biscuit, cracker, wafer, noodles and pasta they will also focus on the distribution of our food enzymes portfolio for protein processing and modification as well as grain and fruit processing.